Hydrogen -rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome

Journal of Lipid Research

Volumn 54, Issue 7, 2013, Pages 1884-1893

  Song, Guohua ^a,b   Li, Min ^b   Sang, Hui ^b   Zhang, Liying ^b   Li, Xiuhong ^c   Yao, Shutong ^b   Yu, Yang ^a,b   Zong, Chuanlong ^a,b   Xue, Yazhuo ^b   Qin, Shucun ^a,b  

^a Universities of Shandong   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c Taishan Mental Diseases Hospital   (China)

Author keywords

Antioxidative property; Apolipoprotein B; High density lipoprotein; Low density lipoprotein

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; HYDROGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; WATER;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ADHESION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; DYSLIPIDEMIA; FEMALE; FLUID INTAKE; HUMAN; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT OUTCOME; WESTERN BLOTTING;

ANTIOXIDATIVE PROPERTY; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ANTIOXIDANTS; APOLIPOPROTEINS B; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROGEN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; WATER;

EID: 84878976217     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M036640     Document Type: Article

References (30)

1. Ohsawa, I., M. Ishikawa, K. Takahashi, M. Watanabe, K. Nishimaki, K. Yamagata, K. Katsura, Y. Katayama, S. Asoh, and S. Ohta. 2007. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 13: 688-694.
2. Amitani, H., A. Asakawa, K. Cheng, M. Amitani, K. Kaimoto, M. Nakano, M. Ushikai, Y. Li, M. Tsai, J. B. Li, et al. 2013. Hydrogen improves glycemic control in type1 diabetic animal model by promoting glucose uptake into skeletal muscle. PLoS ONE. 8: e53913.
3. Kajiyama, S., G. Hasegawa, M. Asano, H. Hosoda, M. Fukui, N. Nakamura, J. Kitawaki, S. Imai, K. Nakano, M. Ohta, et al. 2008. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr. Res. 28: 137-143.
4. Gharib, B., S. Hanna, O. M. Abdallahi, H. Lepidi, B. Gardette, and M. De Reggi. 2001. Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation. C. R. Acad. Sci. III. 324: 719-724. (Pubitemid 32707449)
5. Song, G., H. Tian, S. Qin, X. Sun, S. Yao, C. Zong, Y. Luo, J. Liu, Y. Yu, H. Sang, et al. 2012. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice. Atherosclerosis. 221: 55-65.
6. Zong, C., G. Song, S. Yao, L. Li, Y. Yu, L. Feng, S. Guo, T. Luo, and S. Qin. 2012. Administration of hydrogen-saturated saline decreases plasma low-density lipoprotein cholesterol levels and improves high-density lipoprotein function in high-fat diet-fed hamsters. Metabolism. 61: 794-800.
7. Furukawa, S., T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, and I. Shimomura. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114: 1752-1761. (Pubitemid 40385531)
8. Holvoet, P., D. H. Lee, M. Steffes, M. Gross, and D. R. Jacobs, Jr. 2008. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA. 299: 2287-2293. (Pubitemid 351724395)
9. Ford, E. S., W. H. Giles, and W. H. Dietz. 2002. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 287: 356-359. (Pubitemid 34251969)
10. Grundy, S. M., H. B. Brewer, Jr., J. I. Cleeman, S. C. Smith, Jr., and C. Lenfant. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109: 433-438. (Pubitemid 38133916)
11. Cifuentes-Goches, J. C., D. Gomez-Lopez Jde, L. Hernandez-Ancheyta, S. E. Flores-Fuentes, J. L. Inchaustegui-Arias, and A. O. Canas-Urbina. 2012. Hypertriglyceridemia and low HDL cholesterol as high impact factors for metabolic syndrome diagnosis in apparently healthy adults [in Spanish]. Rev. Med. Inst. Mex. Seguro Soc. 50: 301-306.
12. Van Lenten, B. J., M. Navab, D. Shih, A. M. Fogelman, and A. J. Lusis. 2001. The role of high-density lipoproteins in oxidation and inflammation. Trends Cardiovasc. Med. 11: 155-161. (Pubitemid 33070340)
13. Tamada, M., S. Makita, A. Abiko, Y. Naganuma, M. Nagai, and M. Nakamura. 2010. Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis. Metabolism. 59: 653-657.
14. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196. (Pubitemid 38802622)
15. Esteve, E., W. Ricart, and J. M. Fernandez-Real. 2005. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin. Nutr. 24: 16-31.
16. Suzuki, Y., M. Sano, K. Hayashida, I. Ohsawa, S. Ohta, and K. Fukuda. 2009. Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract? FEBS Lett. 583: 2157-2159.
17. Jiang, X. C., L. Masucci-Magoulas, J. Mar, M. Lin, A. Walsh, J. L. Breslow, and A. Tall. 1993. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. J. Biol. Chem. 268: 27406-27412. (Pubitemid 24006464)
18. Itahara, T., T. Suehiro, Y. Ikeda, M. Inoue, T. Nakamura, Y. Kumon, M. Kawada, and K. Hashimoto. 2000. Serum paraoxonase and arylesterase activities in hemodialysis patients. J. Atheroscler. Thromb. 7: 152-158.
19. Jiang, X. C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914. (Pubitemid 29152637)
20. Rikitake, Y., K. Hirata, S. Kawashima, H. Akita, and M. Yokoyama. 1998. Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells. Atherosclerosis. 136: 51-57. (Pubitemid 28341441)
21. McCrohon, J. A., W. Jessup, D. J. Handelsman, and D. S. Celermajer. 1999. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation. 99: 2317-2322. (Pubitemid 29201140)
22. Smith, J. D., M. Miyata, M. Ginsberg, C. Grigaux, E. Shmookler, and A. S. Plump. 1996. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271: 30647-30655. (Pubitemid 26404080)
23. Basu, S. K., M. S. Brown, Y. K. Ho, R. J. Havel, and J. L. Goldstein. 1981. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc. Natl. Acad. Sci. USA. 78: 7545-7549. (Pubitemid 12186179)
24. Mori, M., Y. Sadahira, S. Kawasaki, T. Hayashi, and M. Awai. 1990. Macrophage heterogeneity in bone marrow culture in vitro. J. Cell Sci. 95: 481-485.
25. Ohsawa, I., K. Nishimaki, K. Yamagata, M. Ishikawa, and S. Ohta. 2008. Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem. Biophys. Res. Commun. 377: 1195-1198.
26. Kolovou, G., K. Anagnostopoulou, D. P. Mikhailidis, and D. V. Cokkinos. 2008. Apolipoprotein E knockout models. Curr. Pharm. Des. 14: 338-351. (Pubitemid 351516858)
27. Geurian, K., J. B. Pinson, and C. W. Weart. 1992. The triglyceride connection in atherosclerosis. Ann. Pharmacother. 26: 1109-1117.
28. Ma, P. T., G. Gil, T. C. Sudhof, D. W. Bilheimer, J. L. Goldstein, and M. S. Brown. 1986. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc. Natl. Acad. Sci. USA. 83: 8370-8374. (Pubitemid 17182502)
29. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62: 707-714. (Pubitemid 8110784)
30. Kontush, A., and M. J. Chapman. 2006. Functionally defective highdensity lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58: 342-374. (Pubitemid 44394906)